New data shows nearly three‑year median overall survival
Category: News
SMC decision expands options for people with chronic itch
New treatment option expands paediatric HIV care access
Australian teams advance first‑in‑human multiple myeloma therapy
Designation supports development for post‑hepatectomy liver failure
New treatment reduces pathogenic IgG while preserving B‑cell function
Phase 2 study to assess muscarinic M1 agonist in Alzheimer’s cognition
sBLA covers dMMR/MSI‑H stage II–III rectal cancer
Anthropic, twist and Adaptyv validate 1,320 binders across 15 targets
